{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:04:16Z","timestamp":1793657056524,"version":"4.5.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["M688"],"award-info":[{"award-number":["M688"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004299","name":"Secretar\u00eda de Educaci\u00f3n Superior, Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010059","name":"University of Nigeria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010059","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mexican National Council for Science and Technology"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oxford Immunotec"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To examine the expression of Free fatty acid receptor 2 (FFAR2) and Suppressor of cytokine signalling 3 (SOCS3) genes in asymptomatic hyperuricaemia (AH), AH with MSU crystal deposition, inter-critical gout and gout flare.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Study participants (n\u2009=\u2009120) comprised 34 people with serum urate (SU) &amp;lt;360 \u03bcmol\/l, 69 with AH \u00b1 MSU crystal deposition and 17 with a gout flare. Sixteen of the 17 patients with a gout flare attended a second visit 6\u201312\u2009weeks later. Gene expression levels were assessed using RT-qPCR and results computed as fold changes (FC) after normalization to the reference gene.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>FFAR2 was significantly upregulated during gout flares (FC\u2009=\u20092.9) compared with normal SU, AH, and AH + MSU crystal deposition (FC\u2009=\u20091.1, P\u2009&amp;lt;\u20090.0001 for each comparison). FFAR2 was also significantly upregulated during inter-critical gout (FC\u2009=\u20091.8) compared with normal SU, AH and AH + MSU (FC\u2009=\u20091.1, P\u2009&amp;lt;\u20090.001 for each comparison). SOCS3 was significantly upregulated during gout flares (FC\u2009=\u20093.4) compared with normal SU, AH, and AH + MSU crystal deposition (FC\u2009=\u20091.1, 1.1 and 1.2, respectively, P\u2009&amp;lt;\u20090.0001 for each comparison). SOCS3 was also upregulated during inter-critical gout (FC\u2009=\u20092.1) compared with normal SU (P\u2009=\u20090.02) and AH (P\u2009=\u20090.006) (FC\u2009=\u20091.1 and 1.2, respectively). FFAR2 expression was upregulated during gout flare compared with inter-critical gout and SOCS3 expression showed negative correlation with flare duration (r\u2009=\u2009\u20130.49, P\u2009&amp;lt;\u20090.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>FFAR2 upregulation is associated with gout and may trigger gout flares. SOCS3 may have a role in amelioration of gout flares.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac360","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T14:00:14Z","timestamp":1655906414000},"page":"977-983","source":"Crossref","is-referenced-by-count":9,"title":["Upregulated expression of <i>FFAR2<\/i> and <i>SOC3<\/i> genes is associated with gout"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3285-8242","authenticated-orcid":false,"given":"Oliver C","family":"Orji","sequence":"first","affiliation":[{"name":"Human Genetics, School of Life Sciences, Faculty of Medicine and Health Sciences , University of Nottingham, Nottingham, UK"},{"name":"Department of Medical Laboratory Sciences, College of Medicine, University of Nigeria, Enugu Campus , Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria B","family":"L\u00f3pez-Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Human Genetics, School of Life Sciences, Faculty of Medicine and Health Sciences , University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Sandoval-Plata","sequence":"additional","affiliation":[{"name":"Human Genetics, School of Life Sciences, Faculty of Medicine and Health Sciences , University of Nottingham, Nottingham, UK"},{"name":"Academic Rheumatology, School of Medicine, Nottingham City Hospital, University of Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Guetta-Baranes","sequence":"additional","affiliation":[{"name":"Human Genetics, School of Life Sciences, Faculty of Medicine and Health Sciences , University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M","family":"Valdes","sequence":"additional","affiliation":[{"name":"Academic Rheumatology, School of Medicine, Nottingham City Hospital, University of Nottingham"},{"name":"Nottingham NIHR BRC , Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doherty","sequence":"additional","affiliation":[{"name":"Academic Rheumatology, School of Medicine, Nottingham City Hospital, University of Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Morgan","sequence":"additional","affiliation":[{"name":"Human Genetics, School of Life Sciences, Faculty of Medicine and Health Sciences , University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0121-4919","authenticated-orcid":false,"given":"Abhishek","family":"Abhishek","sequence":"additional","affiliation":[{"name":"Academic Rheumatology, School of Medicine, Nottingham City Hospital, University of Nottingham"},{"name":"Nottingham NIHR BRC , Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"2023020117335398100_keac360-B1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng.2500","article-title":"Genome-wide association analyses identify 18 new loci associated with serum urate concentrations","volume":"45","author":"K\u00f6ttgen","year":"2013","journal-title":"Nat Genet"},{"key":"2023020117335398100_keac360-B2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"2023020117335398100_keac360-B3","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"2023020117335398100_keac360-B4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.39107","article-title":"A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout","volume":"67","author":"Vieira","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2023020117335398100_keac360-B5","doi-asserted-by":"crossref","first-page":"650812","DOI":"10.1155\/2013\/650812","article-title":"SOCS3 expression correlates with severity of inflammation, expression of proinflammatory cytokines, and activation of STAT3 and p38 MAPK in LPS-induced inflammation in vivo","volume":"2013","author":"Chaves de Souza","year":"2013","journal-title":"Mediat Inflamm"},{"key":"2023020117335398100_keac360-B6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/annrheumdis-2014-207201","article-title":"Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors","volume":"75","author":"Gao","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2023020117335398100_keac360-B7","doi-asserted-by":"crossref","first-page":"i70","DOI":"10.1136\/annrheumdis-2011-200595","article-title":"In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis","volume":"71","author":"Tanaka","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2023020117335398100_keac360-B8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.immuni.2011.12.015","article-title":"Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity","volume":"36","author":"Babon","year":"2012","journal-title":"Immunity"},{"key":"2023020117335398100_keac360-B9","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/art.40572","article-title":"Brief Report: monosodium urate monohydrate crystal deposits are common in asymptomatic sons of patients with gout: the Sons of Gout study","volume":"70","author":"Abhishek","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2023020117335398100_keac360-B10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2023020117335398100_keac360-B11","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","article-title":"Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1\u03b2 production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis","volume":"62","author":"Joosten","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2023020117335398100_keac360-B12","doi-asserted-by":"crossref","first-page":"e21205","DOI":"10.1371\/journal.pone.0021205","article-title":"SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor","volume":"6","author":"Vinolo","year":"2011","journal-title":"PLoS ONE"},{"key":"2023020117335398100_keac360-B13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ibd\/izx029","article-title":"A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease","volume":"24","author":"Gon\u00e7alves","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2023020117335398100_keac360-B14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fimmu.2016.00028","article-title":"GPR41 and GPR43 in obesity and inflammation\u2009-\u2009protective or causative?","volume":"7","author":"Ang","year":"2016","journal-title":"Front Immunol"},{"key":"2023020117335398100_keac360-B15","doi-asserted-by":"crossref","first-page":"773261","DOI":"10.3389\/fimmu.2022.773261","article-title":"Acetate improves the killing of streptococcus pneumoniae by alveolar macrophages via NLRP3 inflammasome and glycolysis-HIF-1\u03b1 axis","volume":"13","author":"Machado","year":"2022","journal-title":"Front Immunol"},{"key":"2023020117335398100_keac360-B16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13075-022-02742-9","article-title":"Treatment of gouty arthritis is associated with restoring the gut microbiota and promoting the production of short-chain fatty acids","volume":"24","author":"Park","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2023020117335398100_keac360-B17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1189\/jlb.3A1015-453RRR","article-title":"Dietary fiber and the short-chain fatty acid acetate promote resolution of neutrophilic inflammation in a model of gout in mice","volume":"101","author":"Vieira","year":"2017","journal-title":"J Leukocyte Biol"},{"key":"2023020117335398100_keac360-B18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.redox.2018.02.007","article-title":"Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: antioxidant action of butyrate","volume":"16","author":"Yuan","year":"2018","journal-title":"Redox Biol"},{"key":"2023020117335398100_keac360-B19","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1136\/ard.2010.145821","article-title":"Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGF\u03b21, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3","volume":"70","author":"Chen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2023020117335398100_keac360-B20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13075-016-1167-y","article-title":"Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout","volume":"18","author":"Liu","year":"2016","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac360\/44551951\/keac360.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/2\/977\/49031581\/keac360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/2\/977\/49031581\/keac360.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:44:08Z","timestamp":1675298648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/2\/977\/6613128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6,22]]},"published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac360","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,6,22]]}}}